Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The p53 network is vital for suppressing tumors, regulating cell cycle arrest, apoptosis, and senescence.
• Metabolic alterations linked to p53's function are an emerging area of research.
• Understanding p53's regulatory targets is key to deciphering its tumor-suppressive mechanisms.

Purpose of the Study:

• To identify novel p53 target genes involved in metabolic regulation.
• To investigate the role of GMP synthetase (GMPS) in the p53 pathway.
• To elucidate the functional significance of GMPS repression by p53 in liver cancer.

Main Methods:

• Large-scale proteomics to identify p53 repression targets.
• Immunoblotting to validate p53-mediated repression of GMP synthetase (GMPS).
• RNA interference to assess the impact of GMPS knockdown on cell viability and senescence.
• Comparison of GMPS expression in murine hepatocellular carcinomas with different p53 statuses.

Main Results:

• GMP synthetase (GMPS), a key enzyme in purine biosynthesis, was identified as a p53 repression target.
• p53-mediated repression of GMPS was validated in human liver cancer cell lines and occurs in a p21-dependent manner.
• GMPS knockdown reduced cell viability and induced cellular senescence.
• Higher GMPS expression was observed in p53-null murine hepatocellular carcinomas compared to p53 wild-type counterparts.

Conclusions:

• Repression of GMP synthetase (GMPS) by p53, mediated through p21, is a functionally relevant component of the p53-induced senescence program.
• This mechanism contributes to limiting tumor cell growth in liver cancer.
• Targeting GMPS may offer a therapeutic strategy for liver cancer by reactivating p53-dependent tumor suppression.